Back to Trials
NCT00985049Recruiting

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)

Brigham and Women's Hospital

Start Date

3/1/2009

Completion Date

12/1/2025

Summary

Hypothesis: The investigators hypothesize that genetic variants will alter gene expression in response to ischemia during cardiopulmonary bypass. To test this, the investigators will be taking small pieces of heart tissue from patients undergoing heart surgery before and after this period of ischemia. This will be compared to blood gene expression in blood cells and analyzed with the patients' genetic profile. This might allow us to assess the amount of inflammation that occurs when patients are on the heart-lung machine as well as examine the effects genes have on this critical time period.

Eligibility Criteria

Age Range: 20 years to No maximum

Inclusion Criteria: * Aged greater than 20 years * Undergoing aortic valve surgery with or without CABG surgery * Receive and apical vent as part of the surgery Exclusion Criteria: * Will not receive an apical left ventricular vent

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cardiovascular Diseases

Locations

Brigham and Women's Hospital

Boston, Massachusetts 02115

United States